| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9895 |
| Human Intestinal Absorption | HIA+ | 0.9851 |
| Caco-2 Permeability | Caco2+ | 0.7983 |
| P-glycoprotein Substrate | Non-substrate | 0.7440 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9092 |
| Non-inhibitor | 0.9241 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9022 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5086 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8506 |
| CYP450 2D6 Substrate | Non-substrate | 0.8894 |
| CYP450 3A4 Substrate | Non-substrate | 0.6345 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6332 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9495 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9557 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9467 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9871 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9327 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9510 |
| Non-inhibitor | 0.9371 |
| AMES Toxicity | Non AMES toxic | 0.9604 |
| Carcinogens | Carcinogens | 0.5680 |
| Fish Toxicity | High FHMT | 0.5269 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8366 |
| Honey Bee Toxicity | High HBT | 0.7767 |
| Biodegradation | Ready biodegradable | 0.9391 |
| Acute Oral Toxicity | III | 0.8509 |
| Carcinogenicity (Three-class) | Non-required | 0.6880 |